Introduction
It is usually said that in a hepatic illness it is safe to resume oral contraception after the acute phase of the disease is over. To try to establish a more precise, workable ruling we took 14 days after the bilirubin and serum aminotransferase tests had returned to normal as the starting point for resuming oral contraceptives in a small group of women recovering from virus hepatitis. In another, smaller group of women who had had an operation for obstructive jaundice we started oral contraceptives eight weeks after the operation. In each group we observed the effect of the oral contraceptives on the liver function tests at fortnightly intervals, and the results are reported. normal under 18 IU/1.), ornithine carbamyltransferase (normal under 0 4 unit), alkaline phosphatase (normal under 2-9 BesseyLowry units), and total serum bilirubin were determined at two-weekly intervals.
Patients and Methods

Results
Hepatitis Group.-In the acute stage of the illness the highest serum levels of aspartate aminotransferase and alanine aminotransferase were 540 and 1,500 IU respectively. The medians were 269 and 463 IU (Fig. 1) . The highest level of ornithine carbamyltransferase was 2-63 units, of total serum bilirubin 14-1 mg/100 ml, and of alkaline phosphatase 10-2 Bessey-Lowry units. Administration of contraceptives was started after the serum aspartate aminotransferase and alanine aminotransferase had become within normal limits and the alkaline phosphatase and total serum bilirubin had returned to normal, but in four patients the ornithine carbamyltransferase was still raised (0-53-0-68 unit). In some patients the serum aspartate aminotransferase and alanine aminotransferase rose above the normal upper limit during the first month of oral contraception, but they returned to normal afterwards. Likewise the serum ornithine carbamyltransferase gradually returned to normal in those cases in which it was raised when oral contraceptives were begun. The total serum bilirubin and alkaline phosphatase remained normal all through the follow-up. Obstructive 7aundice Group.-The maximal values in the acute stage varied from patient to patient as follows: total serum bilirubin 1-5-5-7 mg/100 ml, aspartate aminotransferase 25-182 IU, alanine aminotransferase 46-175 IU, ornithine carbamyltransferase 0-66-2-22 units, and alkaline phosphatase 4-0-14-1 Bessy-Lowry units. When Volidan was being taken the serum enzymes stayed within normal limits except in one case (Fig. 2) . In this woman, aged 21, the serum enzymes when Volidan was started were aspartate aminotransferase 22 IU, alanine aminotransferase 30 IU, ornithine carbamyltransferase 0-76 unit, and alkaline phosphatase 7-8 BesseyLowry units. The obstructive jaundice was caused in her case by acute cholecystitis. After 11 weeks on Volidan the serum aspartate aminotransferase was 25 IU and the alanine amino- transferase 38 IU. The total serum bilirubin remained throughout at 1 mg/100 ml. Despite cholestasis the raised alkaline phosphatase gradually fell to normal in 11 weeks (Fig. 3) .
Discussion
Because many drugs are metabolized in the liver they must be prescribed with great caution in patients with acute liver damage. However, the ability to metabolize drugs is restored after reversible liver disease, and a return to normal of the liver function tests could be taken as a guide to when the administration of drugs could safely be resumed. We started oral contraceptives in our cases of virus hepatitis two weeks after the levels of serum aminotransferases returned to normal. These enzymes remained within normal limits while oral contraceptives were being taken. In some patients serum aminotransferases were slightly raised during the first month of administration, but they soon returned to normal. This is in agreement with earlier observations (Roman and Hecker, 1968; Hargreaves, 1970) . On the other hand, the levels of serum ornithine carbamyltransferase either remained within normal limits all the time or gradually returned to normal without any transient fluctuations. The previous use of oral contraceptives did not seem to influence the clinical course of the hepatitis or the serum enzyme levels in the trial period.
In women who had recovered from obstructive jaundice the serum enzyme levels remained within normal limits while Volidan was being taken. In one patient an initial alkaline phosphatase level of 7-8 Bessey-Lowry units gradually became normal. A lever biopsy specimen from this patient showed the type of cholestasis which has been reported to be typical in jaundice caused by oral contraceptives (Boake et al., 1965; Eisalo and Rasanen, 1965; Larsson-Cohn and Stenram, 1965) . However, since the alkaline phosphatase and serum bilirubin were normal the cholestasis was not aggravated by oral contraceptives.
It seems reasonable to assume that some additional factor or factors must be present in the causation of jaundice or changes in the liver function tests by oral contraceptives. There is some evidence that the results of laboratory tests may be related to the dose of contraceptive, and alterations in the liver function tests seem more common in postmenopausal women than in women of childbearing age. Furthermore, it has been frequently reported that women in whom an oral contraceptive causes jaundice or abnormal liver function tests often have a history of jaundice in late pregancy (Adlercreutz and Ikonen, 1964; Boake et al., 1965; Haemmerli and Wyss, 1967; Schmid, 1969; Westerholm, 1970; Ylostalo, 1970) . Unfortunately one of the most essential questions-the significance of the molecular structure of the steroids in oral contraceptives and the possible individual differences in response to different steroids-remains unanswered. It will be clarified when the metabolic fate of the synthetic steroids is known.
